Publikasjoner

​Publikasjoner

Klebaner D, Hamilton-Dutoit S, Ahern T, Crawford A, Jakobsen T, Cronin-Fenton DP, Damkier P, Janssen E, Kjaersgaard A, Ording AG, Søiland H, Sørensen HT, Lash TL, Hellberg Y
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.
PLoS One 2017;12(3):e0171453. Epub 2017 mar 16
PMID: 28301514

Solbrække KN, Søiland H, Lode K, Gripsrud BH
Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
Med Health Care Philos 2017 Mar;20(1):89-103.
PMID: 27709396

Damkier P, Kjærsgaard A, Barker KA, Cronin-Fenton D, Crawford A, Hellberg Y, Janssen EAM, Langefeld C, Ahern TP, Lash TL
CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.
Sci Rep 2017 Aug 10;7(1):7727. Epub 2017 aug 10
PMID: 28798474

Klimov S, Rida PC, Aleskandarany MA, Green AR, Ellis IO, Janssen EA, Rakha EA, Aneja R
Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers.
Br J Cancer 2017 Sep 05;117(6):826-834. Epub 2017 jul 18
PMID: 28720841

Mittal K, Choi DH, Ogden A, Donthamsetty S, Melton BD, Gupta MV, Pannu V, Cantuaria G, Varambally S, Reid MD, Jonsdottir K, Janssen EA, Aleskandarany MA, Ellis IO, Rakha EA, Rida PC, Aneja R
Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells.
Sci Rep 2017 Mar 08;7():43984. Epub 2017 mar 8
PMID: 28272508

Thistle JE, Hellberg Y, Mortensen K, Hamilton-Dutoit S, Kjærsgaard A, Cronin-Fenton D, Sørensen HT, Lash TL
The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study.
Breast Cancer Res Treat 2017 Oct;165(3):633-643. Epub 2017 jun 22
PMID: 28643021

Cronin-Fenton DP, Kjærsgaard A, Ahern TP, Mele M, Ewertz M, Hamilton-Dutoit S, Christiansen PM, Ejlertsen B, Sørensen HT, Lash TL, Silliman RA
Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study.
Acta Oncol 2017 Sep;56(9):1155-1160. Epub 2017 jun 6
PMID: 28585885

Silverberg MJ, Nash R, Becerra-Culqui TA, Cromwell L, Getahun D, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Slovis J, Tangpricha V, Goodman M
Cohort study of cancer risk among insured transgender people.
Ann Epidemiol 2017 Aug;27(8):499-501. Epub 2017 jul 22
PMID: 28780974

Ahern TP, Hertz DL, Damkier P, Ejlertsen B, Hamilton-Dutoit SJ, Rae JM, Regan MM, Thompson AM, Lash TL, Cronin-Fenton DP
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.
Am J Epidemiol 2017 Jan 15;185(2):75-85. Epub 2016 des 17
PMID: 27988492

Helland T, Henne N, Bifulco E, Naume B, Borgen E, Kristensen VN, Kvaløy JT, Lash TL, Alnæs GIG, van Schaik RH, Janssen EAM, Hustad S, Lien EA, Mellgren G, Søiland H
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.
Breast Cancer Res 2017 Nov 28;19(1):125. Epub 2017 nov 28
PMID: 29183390

Hagen KB, Aas T, Kvaløy JT, Eriksen HR, Søiland H, Lind R
Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls.
Breast 2016 Aug;28():100-6. Epub 2016 jun 2
PMID: 27262826

Gripsrud BH, Brassil KJ, Summers B, Søiland H, Kronowitz S, Lode K
Capturing the Experience: Reflections of Women With Breast Cancer Engaged in an Expressive Writing Intervention.
Cancer Nurs 2016 Jul-Aug;39(4):E51-60.
PMID: 26390074

Hagen KB, Aas T, Lode K, Gjerde J, Lien E, Kvaløy JT, Lash TL, Søiland H, Lind R
Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness Scale.
Eur J Oncol Nurs 2015 Apr;19(2):113-9. Epub 2014 des 20
PMID: 25538036

Helland T, Gjerde J, Dankel S, Fenne IS, Skartveit L, Drangevåg A, Bozickovic O, Flågeng MH, Søiland H, Mellgren G, Lien EA
The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells.
PLoS One 2015;10(4):e0122339. Epub 2015 apr 13
PMID: 25867603

Hagen KB, Aas T, Kvaløy JT, Søiland H and Lind R.
Diet in women with breast cancer compared to healthy controls; What is the difference?
European Journal of Oncology Nursing. 32: 20-4., dec 2017
Gripsrud BH, Søiland H, Lode K
Ekspressiv skriving som egenterapeutisk verktøy ett år etter brystkreftdiagnosen - resultater fra en norsk pilotstudie
Nordisk tidsskrift for helseforskning, 2014

Fant du det du lette etter?
Tilbakemeldingen vil ikke bli besvart. Ikke send personlig informasjon, for eksempel epost, telefonnummer eller personnummer.